Midfielder missed final training session before Haiti game ‘Hopefully that doesn’t spread,’ said Kenny McLean Scotland are confident Scott McTominay will be fit to face Haiti on Saturday despite the midfielder sitting out training on Thursday due to a stomach complaint. McTominay, widely considered Scotland’s most influential player, was a notable absentee as Steve Clarke put his players through t...
Midfielder missed final training session before Haiti game ‘Hopefully that doesn’t spread,’ said Kenny McLean Scotland are confident Scott McTominay will be fit to face Haiti on Saturday despite the midfielder sitting out training on Thursday due to a stomach complaint. McTominay, widely considered Scotland’s most influential player, was a notable absentee as Steve Clarke put his players through their paces for a final time in North Carolina before departing for Boston. There, Scotland will play their first World Cup match in 28 years. Continue reading...
British driver says pressure is off following bad run Antonelli 68 points ahead of Mercedes teammate George Russell insists the pressure is off in the battle for the Formula One drivers’ championship after a succession of mishaps this season – combined with the exemplary form of his Mercedes teammate , Kimi Antonelli – left him 68 points off the pace. Sunday’s round seven is the newly styled Barce...
British driver says pressure is off following bad run Antonelli 68 points ahead of Mercedes teammate George Russell insists the pressure is off in the battle for the Formula One drivers’ championship after a succession of mishaps this season – combined with the exemplary form of his Mercedes teammate , Kimi Antonelli – left him 68 points off the pace. Sunday’s round seven is the newly styled Barcelona-Catalunya Grand Prix, with the Spanish Grand Prix shifting to a new venue in Madrid in September. Mercedes are expected to excel again this weekend, but it is the 19-year-old Antonelli who has established a firm grip on the drivers’ championship after five consecutive victories . Continue reading...
Automobiles are increasingly using sophisticated technology suppliers to make their vehicles more energy efficient and safer. Investors are currently weighing the merits of Cognex Corp. (NASDAQ:CGNX) and Power Integrations (NASDAQ:POWI) . Cognex specializes in the sophisticated software and hardware that allow machines to see, while Power Integrations focuses on the chips that manage power convers...
Automobiles are increasingly using sophisticated technology suppliers to make their vehicles more energy efficient and safer. Investors are currently weighing the merits of Cognex Corp. (NASDAQ:CGNX) and Power Integrations (NASDAQ:POWI) . Cognex specializes in the sophisticated software and hardware that allow machines to see, while Power Integrations focuses on the chips that manage power conversion. Both serve critical roles in modern industry, but their financial profiles and market risks offer distinct paths for your capital. Cognex is a global leader in machine vision technology, providing sensors and software that automate manufacturing tasks. The company occupies a prominent position among tech stocks due to its specialized focus on machine vision. Its systems are used to inspect, identify, and guide products in the logistics, automotive, and electronics industries. Continue reading
An expanded deal between Novartis ( NVS ) and privately held Orionis Biosciences for molecular glue drugs on Thursday boosted shares of Monte Rosa Therapeutics ( GLUE ), Kymera Therapeutics ( KYMR ), and Nurix Therapeutics ( NRIX ), which focus on similar drugs. As part of the multiyear partnership, the Swiss drugmaker will leverage Orionis’ Allo-Glue platform and its AI-based drug discovery capab...
An expanded deal between Novartis ( NVS ) and privately held Orionis Biosciences for molecular glue drugs on Thursday boosted shares of Monte Rosa Therapeutics ( GLUE ), Kymera Therapeutics ( KYMR ), and Nurix Therapeutics ( NRIX ), which focus on similar drugs. As part of the multiyear partnership, the Swiss drugmaker will leverage Orionis’ Allo-Glue platform and its AI-based drug discovery capabilities to discover and advance molecular glue medicines for various diseases. In exchange, Waltham, Massachusetts-based Orionis will receive $40M upfront from Novartis ( NVS ) in addition to milestone payments worth up to $1.4B and tiered royalties on net sales of potential products developed under the collaboration. “We are excited to deepen our collaboration with Orionis and to explore the full potential of molecular glue modalities across multiple therapeutic areas,” said Novartis’ ( NVS ) head of Discovery Sciences, John Tallarico. The deal comes at a time when Big Pharma is increasingly turning attention to the molecular glue technology, which enables targeted degradation of disease-causing proteins. In June 2025, Gilead ( GILD ) inked an exclusive deal worth up to $750M with Kymera ( KYMR ) to license a CDK2-directed MGD program targeting cancer. More on Novartis, Kymera Therapeutics, etc. Nurix Therapeutics Deal With Roche Is Worth Betting On Nurix Therapeutics: 'Strong Buy' Due To Roche Deal And Bexobrutideg Expansions Nurix Therapeutics, Inc. (NRIX) Discusses Strategic Collaboration for Development and Commercialization of Bexobrutideg for BTK-Mediated Diseases - Slideshow Biggest stock movers Monday: NRIX, INTC, and more Nurix surges 43% on up to $3B cancer drug deal with Roche
A safety inquiry into the WellBN clinic in Brighton found 78 children were potentially harmed after being given gender medication without proper checks.
A safety inquiry into the WellBN clinic in Brighton found 78 children were potentially harmed after being given gender medication without proper checks.
NASA pushed its Deep Space Network beyond its limits during the Artemis I mission nearly four years ago. The global array of deep space communications antennas couldn't keep up with the routine demands of 40 robotic science missions and the extraordinary surge required by NASA's Orion space capsule as it flew around the Moon. The experience in late 2022 reduced or delayed downlinks from several hi...
NASA pushed its Deep Space Network beyond its limits during the Artemis I mission nearly four years ago. The global array of deep space communications antennas couldn't keep up with the routine demands of 40 robotic science missions and the extraordinary surge required by NASA's Orion space capsule as it flew around the Moon. The experience in late 2022 reduced or delayed downlinks from several high-profile science missions, including the James Webb Space Telescope and Mars rovers, as the data-hungry Artemis I mission took priority on NASA's communications network. And that was before the first Artemis mission with astronauts onboard. When Artemis II launched April 1, NASA called upon the Deep Space Network (DSN) again to connect Mission Control to the Orion capsule as it soared more than a quarter of a million miles from Earth. With a crew of four flying inside the spacecraft, the agency's appetite for data from Orion on Artemis II was even higher than it was on Artemis I. But at a little more than nine days, the Artemis II mission was shorter than the 25 days Artemis I spent in space, helping alleviate the communications overload. Artemis I also launched 10 small CubeSats into deep space, many of which required tracking and telecom services from the DSN. Artemis II carried fewer CubeSats. Read full article Comments
Nobody ever complains about gas station anxiety. You pull in, you fill the tank, you grab a coffee if the line is short, and you are gone in five minutes. That small block of time is the invisible benchmark every electric vehicle has to meet before the average American driver will seriously ...
Nobody ever complains about gas station anxiety. You pull in, you fill the tank, you grab a coffee if the line is short, and you are gone in five minutes. That small block of time is the invisible benchmark every electric vehicle has to meet before the average American driver will seriously ...
The U.S. Office of Personnel Management (OPM) has awarded Oracle a $395.8 million Federal HRIT Modernization Core Human Capital Management (HCM) contract to deliver the federal government's first governmentwide HR platform. Powered by Oracle Fusion Cloud Human Capital Management (HCM), the new platform will replace more than 100 separate systems and serve as the single, governmentwide system of re...
The U.S. Office of Personnel Management (OPM) has awarded Oracle a $395.8 million Federal HRIT Modernization Core Human Capital Management (HCM) contract to deliver the federal government's first governmentwide HR platform. Powered by Oracle Fusion Cloud Human Capital Management (HCM), the new platform will replace more than 100 separate systems and serve as the single, governmentwide system of record for workforce management under OPM's Federal HR 2.0 initiative.